Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas

被引:37
作者
Parhar, P
Ezer, R
Shao, YZ
Allen, JC
Miller, DC
Newcomb, EW
机构
[1] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA
[2] NYU, Inst Canc, New York, NY 10016 USA
[3] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA
[4] NYU, Dept Pediat, Sch Med, Div Pediat Hematol Oncol, New York, NY 10016 USA
来源
MOLECULAR BRAIN RESEARCH | 2005年 / 137卷 / 1-2期
关键词
p53; codon; 72; polymorphisms; high-grade astrocytomas;
D O I
10.1016/j.molbrainres.2005.02.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Polymorphisms in codon 72 of the p53 tumor suppressor gene have been associated with susceptibility to human cancer. We wished to evaluate whether variant allelic forms of the p53 protein were associated with brain tumors. In this study, we scored 135 brain tumor samples (92 adult and 43 pediatric cases consisting of 64 high-grade astrocytomas, and 71 non-astrocytomas) for the P53 Arg72Pro polymorphisms. Our data show that the genotype frequencies of P53 Arg72Pro vary not only between patients with brain tumors and controls, but also between different histological subtypes of brain tumors. Specifically, we found (i) that the genotype distributions of the P53 Arg72Pro between all brain tumors and controls were statistically significant (P < 0.001) as well as their variant allele frequencies between cases and controls (P < 0.001); (ii) that there was a significant increase in the Arg/Pro heterozygous genotype among high-grade astrocytomas compared with non-astrocytomas (P = 0.002); and (iii) that there was a significant increase in the Arg/Pro heterozygous genotype among high-grade astrocytomas containing transdominant as well as recessive p53 mutations compared with controls (P = 0.002). Our results suggest a possible association between P53 Arg72Pro polymorphisms and susceptibility to brain tumors, particularly high-grade astrocytomas. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 28 条
[1]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[2]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[3]  
Bonafé M, 2003, CLIN CANCER RES, V9, P4860
[4]   The codon 72 polymorphic variants of p53 have markedly different apoptotic potential [J].
Dumont, P ;
Leu, JIJ ;
Della Pietra, AC ;
George, DL ;
Murphy, M .
NATURE GENETICS, 2003, 33 (03) :357-365
[5]   Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas [J].
Ezer, R ;
Alonso, M ;
Pereira, E ;
Kim, M ;
Allen, JC ;
Miller, DC ;
Newcomb, EW .
JOURNAL OF NEURO-ONCOLOGY, 2002, 59 (02) :123-134
[6]  
Fan R, 2000, CANCER EPIDEM BIOMAR, V9, P1037
[7]  
FRANKEL RH, 1992, CANCER RES, V52, P1427
[8]  
Hainaut P, 2000, ADV CANCER RES, V77, P81
[9]   HIGHER LUNG-CANCER RISK FOR YOUNGER AFRICAN-AMERICANS WITH THE PRO/PRO P53 GENOTYPE [J].
JIN, XM ;
WU, XF ;
ROTH, JA ;
AMOS, CI ;
KING, TM ;
BRANCH, C ;
HONN, SE ;
SPITZ, MR .
CARCINOGENESIS, 1995, 16 (09) :2205-2208
[10]  
KLEIHUES P, WHO CLASSIFICATION T